{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:57:23Z","timestamp":1785459443718,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003170","name":"National Kidney Foundation of Illinois","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bone.2020.115559","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T22:11:39Z","timestamp":1595887899000},"page":"115559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency"],"prefix":"10.1016","volume":"141","author":[{"given":"Rebecca","family":"Frazier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hodakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaadriana","family":"Zakarija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115559_bb0005","doi-asserted-by":"crossref","unstructured":"Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet (London, England). 2007;370(9586):511\u2013520.","DOI":"10.1016\/S0140-6736(07)61235-5"},{"issue":"4","key":"10.1016\/j.bone.2020.115559_bb0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993\u20132005","volume":"12","author":"McLean","year":"2009","journal-title":"Public Health Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2020.115559_bb0015","first-page":"S83","article-title":"The available intravenous iron formulations: history, efficacy, and toxicology","volume":"21","author":"Auerbach","year":"2017","journal-title":"Hemodial. Int."},{"issue":"12","key":"10.1016\/j.bone.2020.115559_bb0020","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion."},{"issue":"1","key":"10.1016\/j.bone.2020.115559_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40265-014-0332-3","article-title":"Ferric carboxymaltose: a review of its use in iron deficiency","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs."},{"issue":"4","key":"10.1016\/j.bone.2020.115559_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease","volume":"23","author":"Wolf","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"8","key":"10.1016\/j.bone.2020.115559_bb0035","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2020.115559_bb0040","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115559_bb0045","doi-asserted-by":"crossref","unstructured":"Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W. Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight. 2018;3(23).","DOI":"10.1172\/jci.insight.124486"},{"issue":"6","key":"10.1016\/j.bone.2020.115559_bb0050","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1053\/j.gastro.2016.09.050","article-title":"Blood and bone loser","volume":"152","author":"Schaefer","year":"2017","journal-title":"Gastroenterology."},{"issue":"3","key":"10.1016\/j.bone.2020.115559_bb0055","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jbmr.3319","article-title":"Hypophosphatemia, severe bone pain, gait disturbance, and fatigue fractures after iron substitution in inflammatory bowel disease: a case report","volume":"33","author":"Bartko","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115559_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222851","article-title":"Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration","volume":"2018","author":"Klein","year":"2018","journal-title":"BMJ case reports."},{"key":"10.1016\/j.bone.2020.115559_bb0065","doi-asserted-by":"crossref","unstructured":"Moore KL, Kildahl-Andersen O, Kildahl-Andersen R, Tjonnfjord GE. Uncommon adverse effect of a common medication. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2013;133(2):165.","DOI":"10.4045\/tidsskr.12.0494"},{"issue":"3","key":"10.1016\/j.bone.2020.115559_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jbmr.3369","article-title":"Iron supplementation-induced phosphaturic osteomalacia: FGF23 is the culprit","volume":"33","author":"Urbina","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115559_bb0075","doi-asserted-by":"crossref","unstructured":"Maffioli P, Derosa G. Overview of Biochemical Markers of Bone Metabolism. In: Patel VB, Preedy VR, eds. Biomarkers in Bone Disease. Netherlands: Springer, Dordrecht; 2017:3\u201321.","DOI":"10.1007\/978-94-007-7693-7_24"},{"issue":"37","key":"10.1016\/j.bone.2020.115559_bb0080","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.3748\/wjg.15.4638","article-title":"A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases","volume":"15","author":"Bermejo","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bone.2020.115559_bb0085","unstructured":"World Health Organization, Centers for Disease Control and Prevention. Assessing the Iron Status of Populations: Second edition, Including Literature Reviews. 2007."},{"key":"10.1016\/j.bone.2020.115559_bb0090","unstructured":"Food and Drug Administration. Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical. 2007."},{"issue":"12","key":"10.1016\/j.bone.2020.115559_bb0095","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1373\/clinchem.2012.185827","article-title":"Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry","volume":"58","author":"Laha","year":"2012","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.bone.2020.115559_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/apt.15386","article-title":"Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside","volume":"50","author":"Detlie","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bone.2020.115559_bb0105","first-page":"49","article-title":"Severe hypophosphataemia after intravenous iron administration","volume":"72","author":"Blazevic","year":"2014","journal-title":"Neth. J. Med."},{"issue":"4","key":"10.1016\/j.bone.2020.115559_bb0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ejcn.2014.20","article-title":"Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient","volume":"68","author":"Fierz","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.bone.2020.115559_bb0115","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/TP.0b013e3181f00a18","article-title":"Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient","volume":"90","author":"Mani","year":"2010","journal-title":"Transplantation."},{"issue":"11","key":"10.1016\/j.bone.2020.115559_bb0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.tem.2018.08.006","article-title":"FGF23 beyond phosphotropic hormone","volume":"29","author":"Takashi","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bone.2020.115559_bb0125","doi-asserted-by":"crossref","unstructured":"White KE, Econs MJ. Fibroblast growth factor-23. In: Rosen CJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 7 ed. 2025 M Street, NW, Suite 800, Washington, DC 20036: Americal Society for Bone and Mineral Research; 2008:112\u2013116.","DOI":"10.1002\/9780470623992.ch23"},{"key":"10.1016\/j.bone.2020.115559_bb0130","doi-asserted-by":"crossref","unstructured":"Amarnani R, Travis S, Javaid MK. Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia. Rheumatology (Oxford, England). 2020.","DOI":"10.1093\/rheumatology\/kez627"},{"key":"10.1016\/j.bone.2020.115559_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2017.06.005","article-title":"Calcium and bone metabolism indices","volume":"82","author":"Song","year":"2017","journal-title":"Adv. Clin. Chem."},{"issue":"2","key":"10.1016\/j.bone.2020.115559_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","article-title":"Rapid bone loss is associated with increased levels of biochemical markers","volume":"13","author":"Ross","year":"1998","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:51:13Z","timestamp":1757613073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220303392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"alternative-id":["S8756328220303392"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115559","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115559"}}